Jeffrey Alan Wolf
CIK 1381450 · Chief Executive Officer · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.0K
Companies
7
Total Filings
37
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TOVX | Director | — | $0.30 | — | $0 | 4 | 2026-01-06 |
| SCPX | Chief Executive Officer | 3,583,814 | $0.00 | $5.0K | $0 | 1 | 2024-05-17 |
| Scorpius Holdings, Inc. (NHWK) Delisted | Chief Executive Officer | — | $0.41 | — | $0 | 1 | 2022-12-09 |
| Scorpius Holdings, Inc. (HTBX) Delisted | Chief Executive Officer | 1,083,020 | $2.38 | $2.58M | $0 | 16 | 2022-01-03 |
| Theriva Biologics, Inc. (SYN) Delisted | Director | 10,842 | $1.02 | $11.1K | $0 | 10 | 2021-12-27 |
| Theriva Biologics, Inc. (AEN) Delisted | Director | — | — | — | $0 | 3 | 2011-01-07 |
| Theriva Biologics, Inc. (PP) Delisted | Director | — | $26.10 | — | $0 | 1 | 2007-11-06 |
Recent Filings · Page 2 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-12-31 | Theriva Biologics, Inc. (SYN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-25 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-29 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | +900,000 | $0 | EDGAR |
| 2020-01-02 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | +2,880,000 | $0 | EDGAR |
| 2020-01-02 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | +800,000 | $0 | EDGAR |
| 2019-12-05 | Theriva Biologics, Inc. (SYN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-03 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | +800,000 | $0 | EDGAR |
| 2018-12-07 | Theriva Biologics, Inc. (SYN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-10 | Scorpius Holdings, Inc. (HTBX) Delisted | Grant (A) | +665,720 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.